Phase 1 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed AML or High-Risk MDS

Publication date: September 2015 Source:Clinical Lymphoma Myeloma and Leukemia, Volume 15, Supplement 2 Author(s): Anna B. Halpern, Asma Anwar, Bart L. Scott, Pamela S. Becker, Megan Othus, Paul C. Hendrie, Elizabeth M. Ranker, Andrea Perdue, Heather A. Smith, Tara L. Chen, Sarah A. Buckley, Kaysey F. Orlowski, Morgan A. Powell, Elihu H. Estey, Roland B. Walter
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research